Wells Fargo & Company Issues Pessimistic Forecast for Amrize (NYSE:AMRZ) Stock Price

Amrize (NYSE:AMRZGet Free Report) had its target price dropped by stock analysts at Wells Fargo & Company from $65.00 to $58.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target suggests a potential upside of 15.05% from the stock’s previous close.

A number of other equities research analysts have also issued reports on the company. Morgan Stanley set a $63.00 target price on Amrize and gave the company an “overweight” rating in a research note on Monday, June 22nd. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, May 1st. Royal Bank Of Canada reduced their target price on Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a research note on Friday, May 1st. Stephens reissued an “overweight” rating and issued a $65.00 target price on shares of Amrize in a research report on Monday, May 18th. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research note on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $63.00.

Get Our Latest Research Report on AMRZ

Amrize Stock Performance

NYSE:AMRZ opened at $50.41 on Wednesday. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The firm’s fifty day simple moving average is $53.09 and its 200-day simple moving average is $55.60. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The stock has a market cap of $27.88 billion and a PE ratio of 23.94.

Amrize (NYSE:AMRZGet Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The firm had revenue of $2.18 billion for the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. Analysts expect that Amrize will post 2.75 earnings per share for the current fiscal year.

Insider Transactions at Amrize

In other Amrize news, insider Nollaig Forrest acquired 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was purchased at an average cost of $50.25 per share, for a total transaction of $100,500.00. Following the completion of the acquisition, the insider owned 20,139 shares of the company’s stock, valued at approximately $1,011,984.75. This trade represents a 11.03% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CTO Roald Brouwer acquired 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The shares were purchased at an average cost of $49.84 per share, with a total value of $74,760.00. Following the completion of the acquisition, the chief technology officer owned 19,757 shares in the company, valued at $984,688.88. This trade represents a 8.22% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 54,920 shares of company stock worth $2,717,429 in the last ninety days. Company insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its position in shares of Amrize by 5.6% in the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock valued at $1,722,500,000 after purchasing an additional 1,676,843 shares during the period. Norges Bank bought a new position in shares of Amrize during the fourth quarter valued at $929,333,000. Wellington Management Group LLP grew its position in shares of Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after buying an additional 3,809,133 shares during the last quarter. Harris Associates L P bought a new stake in shares of Amrize in the 4th quarter valued at about $615,406,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Amrize by 1.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,674,921 shares of the company’s stock valued at $532,076,000 after buying an additional 156,903 shares during the period.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.